ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38 | -93.2% | 7,821 | -93.1% | 0.00% | – |
| Q1 2023 | $559 | -97.5% | 113,349 | +5429.2% | 0.00% | – |
| Q3 2022 | $22,000 | -77.6% | 2,050 | -69.0% | 0.00% | – |
| Q4 2021 | $98,000 | -10.9% | 6,605 | +59.2% | 0.00% | – |
| Q3 2021 | $110,000 | -2.7% | 4,150 | -4.6% | 0.00% | – |
| Q2 2021 | $113,000 | -84.5% | 4,350 | -79.0% | 0.00% | -100.0% |
| Q1 2021 | $730,000 | +3955.6% | 20,682 | +2760.6% | 0.00% | – |
| Q4 2020 | $18,000 | -55.0% | 723 | -65.7% | 0.00% | – |
| Q1 2020 | $40,000 | +900.0% | 2,109 | +1243.3% | 0.00% | – |
| Q2 2019 | $4,000 | -97.8% | 157 | -97.5% | 0.00% | -100.0% |
| Q1 2019 | $182,000 | +5966.7% | 6,305 | +5288.9% | 0.00% | – |
| Q4 2018 | $3,000 | – | 117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |